The global Hematocrit Testing Market, a critical segment in diagnostic hematology, is poised for steady growth in the coming years. Valued at USD 1.63 billion in 2023, the market is projected to reach USD 2.63 billion by 2032, reflecting a compound annual growth rate (CAGR) of 5.47% from 2024 to 2032. This growth is underpinned by the rising incidence of anemia and chronic diseases, increased...